Ornella Affinito

Dr. Ornella Affinito


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Genomics
Verified
Journal Article
Closed access
OAOrnella Affinito
Ornella Affinito
DPDomenico Palumbo
Domenico Palumbo
AFAnnalisa Fierro
Annalisa Fierro
Mariella CuomoMariella Cuomo
Mariella Cuomo
GRGiulia De Riso
Giulia De Riso
SCSergio Cocozza
Sergio Cocozza

2 April 2018 in BMC Genomics
Verified
Journal Article
Open access
PDF file
DPDomenico Palumbo
Domenico Palumbo
OAOrnella Affinito
Ornella Affinito
AMAntonella Monticelli
Antonella Monticelli
SCSergio Cocozza
Sergio Cocozza
In recent years, epigenetics has gained a central role in the understanding of the process of natural selection. It is now clear how environmental impacts on the methylome could promote methylation variability with direct effects on disease etiology as well as phenotypic and genotypic variations in evolutionary processes. To identify possible factors influencing inter-individual methylation variability, we studied methylation values standard deviation of 166 healthy individuals searching for possible associations with genomic features and evolutionary signatures. We analyzed methylation variability values in relation to CpG cluster density and we found a strong association between them (p-value < 2.2 × 10− 16). Furthermore, we found that genes related to CpGs with high methylation variability values were enriched for immunological pathways; instead, those associated with low ones were enriched for pathways related to basic cellular functions. Finally, we found an association between methylation variability values and signals of both ancient (p-value < 2.2 × 10− 16) and recent selective pressure (p-value < 1 × 10− 4). Our results indicate the presence of an intricate interplay between genetics, epigenetic code and evolutionary constraints in humans.

28 November 2016 in Epigenetics
Verified
Journal Article
Open access
OAOrnella Affinito
Ornella Affinito
GSGiovanni Scala
Giovanni Scala
DPDomenico Palumbo
Domenico Palumbo
EFErmanno Florio
Ermanno Florio
AMAntonella Monticelli
Antonella Monticelli
SCSergio Cocozza
Sergio Cocozza
DNA methylation is often analyzed by reporting the average methylation degree of each cytosine. In this study, we used a single molecule methylation analysis in order to look at the methylation conformation of individual molecules. Using D-aspartate oxidase as a model gene, we performed an in-depth methylation analysis through the developmental stages of 3 different mouse tissues (brain, lung, and gut), where this gene undergoes opposite methylation destiny. This approach allowed us to track both methylation and demethylation processes at high resolution. The complexity of these dynamics was markedly simplified by introducing the concept of methylation classes (MCs), defined as the number of methylated cytosines per molecule, irrespective of their position. The MC concept smooths the stochasticity of the system, allowing a more deterministic description. In this framework, we also propose a mathematical model based on the Markov chain. This model aims to identify the transition probability of a molecule from one MC to another during methylation and demethylation processes. The results of our model suggest that: 1) both processes are ruled by a dominant class of phenomena, namely, the gain or loss of one methyl group at a time; and 2) the probability of a single CpG site becoming methylated or demethylated depends on the methylation status of the whole molecule at that time.

30 July 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
EMElena Montano
Elena Montano
APAlessandra Pollice
Alessandra Pollice
VLvaleria lucci
valeria lucci
GFGeppino Falco
Geppino Falco
OAOrnella Affinito
Ornella Affinito
Tiziana AngrisanoTiziana Angrisano
Tiziana Angrisano
The identification of the molecular mechanisms controlling early cell fate decisions in mammals is of paramount importance as the ability to determine specific lineage differentiation represents a significant opportunity for new therapies. Pancreatic Progenitor Cells (PPCs) constitute a regenerative reserve essential for the maintenance and regeneration of the pancreas. Besides, PPCs represent an excellent model for understanding pathological pancreatic cellular remodeling. Given the lack of valid markers of early endoderm, the identification of new ones is of fundamental importance. Both products of the Ink4a/Arf locus, in addition to being critical cell-cycle regulators, appear to be involved in several disease pathologies. Moreover, the locus’ expression is epigenetically regulated in ES reprogramming processes, thus constituting the ideal candidates to modulate PPCs homeostasis. In this study, starting from mouse embryonic stem cells (mESCs), we analyzed the early stages of pancreatic commitment. By inducing mESCs commitment to the pancreatic lineage, we observed that both products of the Cdkn2a locus, Ink4a and Arf, mark a naïve pancreatic cellular state that resembled PPC-like specification. Treatment with epi-drugs suggests a role for chromatin remodeling in the CDKN2a (Cycline Dependent Kinase Inhibitor 2A) locus regulation in line with previous observations in other cellular systems. Our data considerably improve the comprehension of pancreatic cellular ontogeny, which could be critical for implementing pluripotent stem cells programming and reprogramming toward pancreatic lineage commitment.